GBP2.89
0.14% yesterday
London, Jun 27, 05:36 pm CET
ISIN
GB00BD3VFW73
Symbol
CTEC
Sector

Convatec Group Stock price

GBP2.89
+0.05 1.62% 1M
+0.72 32.86% 6M
+0.71 32.62% YTD
+0.57 24.42% 1Y
+0.79 37.42% 3Y
+1.13 63.75% 5Y
+1.01 53.35% 10Y
+1.01 53.35% 20Y
London, Closing price Fri, Jun 27 2025
+0.00 0.14%
ISIN
GB00BD3VFW73
Symbol
CTEC
Sector

Key metrics

Basic
Market capitalization
GBP5.9b
Enterprise Value
GBP6.7b
Net debt
GBP828.6m
Cash
GBP47.2m
Shares outstanding
2.0b
Valuation (TTM | estimate)
P/E
41.31 | 23.20
P/S
3.53 | 3.37
EV/Sales
4.03 | 3.85
EV/FCF
33.66
P/B
4.82
Dividends
DPS
GBP0.05
Yield 1Y | 5Y
1.75% | 2.21%
Growth 1Y | 5Y
26.40% | 2.38%
Payout 1Y | 3Y
72.30% | 100.94%
Increased
1 Year
Financials (TTM | estimate)
Revenue
GBP1.7b | GBP1.7b
EBITDA
GBP397.7m | GBP473.0m
EBIT
GBP236.8m
Net Income
GBP138.8m | GBP255.5m
Free Cash Flow
GBP199.8m
Growth (TTM | estimate)
Revenue
6.85% | 4.71%
EBITDA
13.69% | 65.18%
EBIT
22.51%
Net Income
46.21% | 84.01%
Free Cash Flow
15.07%
Margin (TTM | estimate)
Gross
56.07%
EBITDA
23.84% | 27.08%
EBIT
14.19%
Net
8.32% | 14.62%
Free Cash Flow
11.97%
Financial Health
Equity Ratio
48.05%
Return on Equity
11.28%
ROCE
10.82%
ROIC
8.50%
Debt/Equity
0.71
More
EPS
GBP0.07
FCF per Share
GBP0.10
Short interest
54.00%
Employees
10.49k
Rev per Employee
GBP160.00k
Show more

Is Convatec Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Convatec Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Convatec Group forecast:

19x Buy
86%
3x Hold
14%

Analyst Opinions

22 Analysts have issued a Convatec Group forecast:

Buy
86%
Hold
14%

Financial data from Convatec Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,668 1,668
7% 7%
100%
- Direct Costs 733 733
7% 7%
44%
936 936
7% 7%
56%
- Selling and Administrative Expenses 612 612
2% 2%
37%
- Research and Development Expense 81 81
2% 2%
5%
398 398
14% 14%
24%
- Depreciation and Amortization 161 161
3% 3%
10%
EBIT (Operating Income) EBIT 237 237
23% 23%
14%
Net Profit 139 139
46% 46%
8%

In millions GBP.

Don't miss a Thing! We will send you all news about Convatec Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions. The company was incorporated in 1978 and is headquartered in Reading, the United Kingdom.

Head office United Kingdom
CEO Karim Bitar
Employees 10,489
Founded 1978
Website www.convatecgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today